Specifically, we used data obtained from the human breast cancer cell lines MCF7 and MDA231, in which SYK acts as a tumor suppressor [17,18,19], and from the human Burkitt lymphoma cell line DG75, in which SYK plays a pro-oncogenic role [19,22]. Here, SYK is linked to neoplasm.